APA (7th ed.) Citation

JS, L., PE, P., DA, H., EB, T., O, B., & EF, S. (2009). Dramatic response to low-dose erlotinib of epidermal growth factor receptor mutation-positive recurrent non-small cell lung cancer after severe cutaneous toxicity. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 4(12), 1585. https://doi.org/10.1097/JTO.0b013e3181bbb2b9

Chicago Style (17th ed.) Citation

JS, Lind, Postmus PE, Heideman DA, Thunnissen EB, Bekers O, and Smit EF. "Dramatic Response to Low-dose Erlotinib of Epidermal Growth Factor Receptor Mutation-positive Recurrent Non-small Cell Lung Cancer After Severe Cutaneous Toxicity." Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer 4, no. 12 (2009): 1585. https://doi.org/10.1097/JTO.0b013e3181bbb2b9.

MLA (9th ed.) Citation

JS, Lind, et al. "Dramatic Response to Low-dose Erlotinib of Epidermal Growth Factor Receptor Mutation-positive Recurrent Non-small Cell Lung Cancer After Severe Cutaneous Toxicity." Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer, vol. 4, no. 12, 2009, p. 1585, https://doi.org/10.1097/JTO.0b013e3181bbb2b9.